HLS Therapeutics to Present at the 8th Annual SVB Leerink Global Healthcare Conference Canada NewsWire TORONTO, Feb. 19, 2019 TORONTO, Feb. 19, 2019 /CNW/ - HLS Therapeutics Inc. ("HLS"...
HLS Therapeutics Announces Graduation to the Toronto Stock Exchange Canada NewsWire TORONTO, Feb. 6, 2019 TORONTO, Feb. 6, 2019 /CNW/ - HLS Therapeutics Inc. ("HLS" or the...
HLS Therapeutics Receives Conditional Approval to Graduate to the Toronto Stock Exchange Canada NewsWire TORONTO, Jan. 29, 2019 TORONTO, Jan. 29, 2019 /CNW/ - HLS Therapeutics Inc...
HLS Therapeutics Announces Q3 2018 Financial Results Canada NewsWire TORONTO, Nov. 15, 2018 REDUCE-IT™ cardiovascular outcomes study of Vascepa®, for which HLS has in-licensed exclusive Canadian...
HLS Therapeutics Announces that Amarin's Vascepa ® (icosapent ethyl) Demonstrates 26% Reduction in Key Secondary Composite Endpoint of Cardiovascular Death, Heart Attack and Stroke in...
HLS Therapeutics to Host 2018 Third Quarter Results Conference Call Canada NewsWire TORONTO, Nov. 1, 2018 TORONTO, Nov. 1, 2018 /CNW/ - HLS Therapeutics Inc. ("HLS" or the...
HLS Therapeutics Announces that Amarin's REDUCE-IT™ Cardiovascular Outcomes Study of Vascepa® (icosapent ethyl) Capsules Met Primary Endpoint Canada NewsWire TORONTO, Sept. 24...
HLS Therapeutics Appoints Tim Hendrickson as CFO Canada NewsWire TORONTO, Sept. 6, 2018 TORONTO, Sept. 6, 2018 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX-V:...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.